Delivery Order SPE2DR25D3103-SPE2DR26F9X41
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 10, 2025, for the supply of Sildenafil 20 mg tablets (90-count units) with a ceiling value of $2,568.38. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and carries an ultimate completion date of December 11, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 5, 2025, for the supply of Sildenafil 20 mg tablets (90-count units) with a contract ceiling value of $1,692.67. This firm fixed-price delivery order, which is set to be completed by November 6, 2025, will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a non-set-aside competitive procurement, reflecting AmerisourceBergen's established...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on January 14, 2026, for the supply of Sildenafil 20 mg tablets (90-count packages) with a ceiling value of $10,779.98 and an ultimate completion date of January 15, 2026. This is a firm fixed-price delivery order executed without set-aside provisions, indicating competitive award. The contract will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for $9,112.24 to supply Sildenafil 20 mg tablets (90-count units) with an ultimate completion date of August 11, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's broader pharmaceutical supply agreement. The place of performance is AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a delivery order valued at $1,063.05 to AmerisourceBergen Drug Corp for the supply of Sildenafil 20 mg tablets (90-count) on January 14, 2026, with an ultimate completion date of January 15, 2026. This competitively awarded, firm fixed-price contract with no set-aside designation will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen Drug Corp's parent company,...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,847.08 to AmerisourceBergen Drug Corp for the supply of Sildenafil 20 mg tablets (90-count) on July 22, 2025, with an ultimate completion date of July 23, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 28, 2025, for the supply of Sildenafil 20 mg tablets (90-count units) with a ceiling value of $5,290.79. This firm fixed-price delivery order, with an ultimate completion date of October 29, 2025, represents a non-set-aside competitive award supporting federal medical procurement requirements. The contract will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 90 tablets of Sildenafil 20 mg, with a ceiling value of $3,938.75. This is a firm fixed price, non-set-aside contract with an ultimate completion date of November 26, 2025. The order will be fulfilled from the vendor's corporate office location in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its headquarters as a major pharmaceutical distributor serving federal medical procurement needs....
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the delivery of Sildenafil 20 mg tablets. The $1,583.24 firm fixed price delivery order has an ultimate completion date of October 31, 2024. The contract is not designated with a set-aside requirement, indicating open competition. AmerisourceBergen Drug Corp is a major pharmaceutical distributor that holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,564,185,965 units of Sildenafil 20 mg tablets in 90-count bottles. The award has a ceiling value of $15,516.36 and a period of performance through April 8, 2024. Amerisourcebergen Drug Corp is the prime contractor and there were no set-aside designations used for this award. This delivery order contract is issued...
- SPE2DR25D3103Indefinite Delivery Contract
- SPE2DR25D3103-SPE2DR26F9X41Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $4,287.67 to AmerSourceBergen Drug Corp on January 14, 2026, for the supply of Sildenafil 20 mg tablets (90-count units). This competitive, firm fixed-price contract has an ultimate completion date of January 15, 2026, and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a non-set-aside procurement executed through open competition, demonstrating AmerSourceBergen's continued capability to meet federal pharmaceutical supply requirements. This delivery order is issued under AmerSourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX), valued at $999,999,999.00 through December 2026. This prime indefinite delivery vehicle serves as a comprehensive global pharmaceutical support mechanism enabling the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including medications, vaccines, syringes, vials, and test kits across multiple therapeutic domains. AmerSourceBergen Drug Corp operates as a subsidiary of parent company Cencora, Inc., which holds its own substantial $999,999,999.00 IDC with DLA extending through December 2031, reinforcing the group's critical role in the federal medical supply chain serving the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.3k | 1/13/26 |